Xoft raises $25M for targeted cancer treatment
Xoft, a Sunnyvale, Calif. company with an X-ray radiation treatment used for breast cancer and endometrial cancer, has raised a fifth round totaling $25 million, according to VentureWire.
The treatment uses targeting technology and tools to pinpoint the area being irradiated, limiting the damage done to… Continue Reading
Life sciences briefing: Wednesday, Aug. 29, 2007
(UPDATED at 3:10pm PT: See below.)
Featured companies: Agendia, EndoGastric Solutions, FlowCo, Gentris, MedManage Systems, ParagonDx, Presidio Pharmaceuticals, Xoova
Presidio Pharma raises $26M for viral treatments — San Francisco’s Presidio Pharmaceuticals, a biotech developing new antiviral drugs, raised $26 million in a second funding round. Investors included Panorama… Continue Reading
Vascular biology biotech TargeGen raises $40M
San Diego’s TargeGen, a biotechnology targeting disease treatments related to abnormal blood-vessel growth, raised $40 million in a fourth funding round. New investors included Innovis Investments, VantagePoint Venture Partners and CTI Life Sciences Fund, joined by existing investors Forward Ventures, Enterprise Partners, Chicago Growth Partners.
TargeGen’s… Continue Reading